Question

A 66-year-old with type 2 diabetes and established ASCVD (prior MI) has A1c 8.2% on metformin. BP and lipids are controlled. Which glucose-lowering agent has proven ASCVD benefit and should be added irrespective of A1c?

Accepted Answer

GLP-1 receptor agonist with CV benefit (e.g., semaglutide)

Answer

Sulfonylurea

Answer

Basal insulin

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Practice question

A 66-year-old with type 2 diabetes and established ASCVD (prior MI) has A1c 8.2% on metformin. BP and lipids are controlled. Which glucose-lowering agent has proven ASCVD benefit and should be added irrespective of A1c?